News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 910 results

Bausch Health settles with Sun Pharma

Canada, India, US23-09-2020Sarah Morgan

Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.

BMS and Dr Reddy’s settle Revlimid suit with generics licence

US22-09-2020Rory O'Neill

Bristol Myers Squibb and Celgene have settled their patent litigation with Dr Reddy’s over a generic version of cancer drug Revlimid.

Gilead accused of illegally paying to delay HIV drug competition

US22-09-2020Muireann Bolger

Biopharmaceutical company Gilead is being sued for allegedly scheming to prevent a generic rival from releasing a competing version of its HIV drug Truvada, according to a class action lawsuit filed by investors in the drug manufacturer.

Biogen loses another battle over MS drug patent

US21-09-2020Muireann Bolger

In a blow for biotechnology company, Biogen, a US federal judge has ruled that its lone surviving patent on multiple-sclerosis drug Tecfidera should remain invalid because the matter had already been resolved by another court.

EPO revokes Copaxone patent, clears path for Mylan

EU17-09-2020Sarah Morgan

The European Patent Office has invalidated and revoked a patent related to Teva’s multiple sclerosis drug Copaxone, in a win for Mylan.

Orexo sues Sun Pharma over opioid dependence generic

Sweden, US16-09-2020Sarah Morgan

Swedish pharmaceutical company Orexo has taken India-based Sun Pharmaceutical to court in the US, over its plans to launch a generic version of Orexo’s opioid dependence treatment.

Judge gives initial approval to Actavis $20m antitrust deal

US15-09-2020Sarah Morgan

A Massachusetts judge has provided her preliminary approval to a $19.9 million settlement in a class action antitrust suit brought against pharmaceutical company Actavis. 

Ruling opens door for Noven’s oestrogen patch generics

US10-09-2020Sarah Morgan

In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Amarin vows to challenge Vascepa patent ruling

International, US04-09-2020Muireann Bolger

Amarin has announced it will seek an en banc rehearing of a decision at the US Court of Appeals for the Federal Circuit that failed to revive its patents on heart medicine Vascepa.

Sigmapharm to appeal Pfizer and BMS’ Eliquis win

03-09-2020Rory O'Neill

Generics maker Sigmapharm Laboratories is appealing against a court win for Pfizer and Bristol Myers Squibb over patents for blood-thinner Eliquis.

Showing 1 to 10 of 910 results

LSIPR